Skip to main content

Table 3 Pathways associated with different network modules.

From: Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes

   

Module

  

KEGG Pathway

1

2

3

4

5

6

7

Metabolism

Amino Acid Metabolism

Cysteine and methionine metabolism

7E-02

      
  

Glycine, serine and threonine metabolism

5E-02

      
  

Valine, leucine and isoleucine degradation

8E-03

      
 

Biosynthesis of Secondary Metabolites

Terpenoid backbone biosynthesis

8E-03

      
 

Carbohydrate Metabolism

Butanoate metabolism

7E-02

      
  

Inositol phosphate metabolism

 

1E-02

     
  

Propanoate metabolism

7E-02

      
  

Pyruvate metabolism

3E-02

      
 

Energy Metabolism

Reductive carboxylate cycle (CO2 fixation)

3E-02

      
 

Glycan Biosynthesis and Metabolism

Glycosaminoglycan degradation

2E-03

      
  

Glycosphingolipid biosynthesis - ganglio series

7E-02

      
  

Heparan sulfate biosynthesis

4E-02

      
 

Lipid Metabolism

Arachidonic acid metabolism

2E-02

      
  

Ether lipid metabolism

8E-02

      
  

Fatty acid elongation in mitochondria

2E-02

      
  

Fatty acid metabolism

3E-02

      
  

Glycerolipid metabolism

2E-03

      
  

Glycerophospholipid metabolism

1E-02

      
  

Sphingolipid metabolism

  

2E-02

    
  

Steroid biosynthesis

  

8E-05

    
  

Synthesis and degradation of ketone bodies

3E-02

      
 

Metabolism of Cofactors and Vitamins

Nicotinate and nicotinamide metabolism

5E-04

      
  

One carbon pool by folate

7E-02

      
 

Metabolism of Other Amino Acids

Selenoamino acid metabolism

4E-02

      
 

Xenobiotics Biodegradation and Metabolism

Benzoate degradation via CoA ligation

6E-02

      
  

Caprolactam degradation

8E-03

      

Genetic Information Processing

Folding, Sorting and Degradation

RNA degradation

    

2E-02

  

Environmental Information Processing

Signal Transduction

ErbB signaling pathway

 

2E-02

     
  

Hedgehog signaling pathway

 

4E-05

     
  

Jak-STAT signaling pathway

      

1E-02

  

MAPK signaling pathway

 

8E-02

 

5E-03

2E-03

  
  

mTOR signaling pathway

 

1E-02

     
  

Notch signaling pathway

     

4E-03

 
  

Phosphatidylinositol signaling system

 

4E-02

     
  

TGF-beta signaling pathway

    

4E-02

1E-02

 
  

VEGF signaling pathway

6E-02

9E-03

     
  

Wnt signaling pathway

 

1E-02

   

1E-04

 
 

Signaling Molecules and Interaction

Cell adhesion molecules (CAMs)

     

3E-02

 
  

Cytokine-cytokine receptor interaction

 

4E-03

    

6E-02

  

ECM-receptor interaction

1E-02

      

Cellular Processes

Cell Communication

Adherens junction

      

3E-02

  

Focal adhesion

1E-02

5E-04

    

3E-02

  

Tight junction

 

4E-04

     
 

Cell Growth and Death

Apoptosis

 

2E-02

     
  

Cell cycle

    

8E-02

  
  

p53 signaling pathway

 

3E-02

     
 

Cell Motility

Regulation of actin cytoskeleton

 

9E-04

     
 

Circulatory System

Vascular smooth muscle contraction

4E-06

      
 

Development

Axon guidance

 

7E-02

    

7E-02

 

Endocrine System

Adipocytokine signaling pathway

 

3E-02

    

2E-06

  

GnRH signaling pathway

 

9E-02

     
  

Insulin signaling pathway

 

2E-05

  

1E-02

 

7E-05

 

Immune System

Antigen processing and presentation

  

8E-02

    
  

B cell receptor signaling pathway

 

8E-03

     
  

Chemokine signaling pathway

 

2E-09

     
  

Complement and coagulation cascades

1E-02

      
  

Fc epsilon RI signaling pathway

 

4E-02

     
  

Fc gamma R-mediated phagocytosis

 

1E-03

     
  

Leukocyte transendothelial migration

 

1E-02

     
  

T cell receptor signaling pathway

 

2E-03

     
  

Toll-like receptor signaling pathway

2E-02

9E-02

     
 

Nervous System

Neurotrophin signaling pathway

 

7E-06

     
 

Transport and Catabolism

Endocytosis

 

3E-04

     

Human Diseases

Cancers

Acute myeloid leukemia

    

2E-02

  
  

Basal cell carcinoma

 

3E-05

     
  

Chronic myeloid leukemia

 

8E-03

   

9E-03

 
  

Colorectal cancer

 

1E-02

  

4E-02

 

3E-02

  

Endometrial cancer

 

6E-02

  

1E-02

  
  

Glioma

 

1E-01

     
  

Pancreatic cancer

 

3E-02

     
  

Pathways in cancer

 

3E-07

   

3E-03

 
  

Prostate cancer

    

4E-02

  
  

Renal cell carcinoma

 

3E-02

     
  

Small cell lung cancer

 

1E-02

     
  

Thyroid cancer

    

5E-03

  
 

Circulatory Diseases

Arrhythmogenic right ventricular cardiomyopathy (ARVC)

6E-02

      
  

Hypertrophic cardiomyopathy (HCM)

      

2E-04

 

Infectious Diseases

Epithelial cell signaling in Helicobacter pylori infection

 

2E-05

     
 

Neurodegenerative Diseases

Amyotrophic lateral sclerosis (ALS)

 

6E-02

     
  1. With genes in each module of the network, pathway enrichment analysis was performed using one-sided Fisher exact test. The significance level of p-value is represented by regular (0.01~0.1), bold (0.0001~0.01) and bold-italic (<0.0001) fonts.